Laird Norton Wetherby Wealth Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,696
Closed -$253K 929
2023
Q2
$253K Buy
+2,696
New +$210K 0.01% 774
2021
Q1
Sell
-1,899
Closed -$252K 819
2020
Q4
$252K Buy
+1,899
New +$230K 0.02% 730

Other funds holding EXAS

Laird Norton Wetherby Wealth Management's EXAS Position: Q3 2023 in Review

Laird Norton Wetherby Wealth Management sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 2,696 shares — an estimated $253K sold.

Laird Norton Wetherby Wealth Management first reported a position in EXAS in Q4 2020 and held it in 2 quarters. The position peaked at $253K in Q2 2023. 624 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.

  • Laird Norton Wetherby Wealth Management reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
  • Laird Norton Wetherby Wealth Management sold 2,696 Exact Sciences shares in Q3 2023, an estimated $253K.
  • Laird Norton Wetherby Wealth Management first reported a position in Exact Sciences in Q4 2020 and held it in 2 quarters.
  • Laird Norton Wetherby Wealth Management's Exact Sciences position peaked at $253K in Q2 2023.
  • 624 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.